But as it turns out, there may be one type of milk that’s nutritionally superior: the organic kind that comes from grass-fed animals. Michael Tunick, a research chemist at the U.S. Department of Agriculture and author of ” The Science of Cheese ,” told Business Insider that the difference has to do with what the cows eat.
Category: Genetics
China Biotech Taps Big Data as Next Weapon in War on Cancer
When Nisa Leung was pregnant with her first child in 2012, her doctor in Hong Kong offered her a choice. She could take a prenatal test that would require inserting a needle into her uterus, or pay $130 more for an exam that would draw a little blood from her arm.
China Biotech Taps Big Data as Next Weapon in War on Cancer
When Nisa Leung was pregnant with her first child in 2012, her doctor in Hong Kong offered her a choice. She could take a prenatal test that would require inserting a needle into her uterus, or pay $130 more for an exam that would draw a little blood from her arm.
Why Crisper Therapeutics Tumbled 12.4% in January
However, ongoing uncertainty about who owns the rights to this intellectual property may have contributed to shares slipping12.4% last month,according to S&P Global Market Intelligence . Crisper Therapeutics is one of a small group of new biotech start-ups that are researching CRISPR-Cas9, an approach that could potentially reshape disease caused by genetic mutation.
Pacific Biosciences of California Reports Bigger Loss in Q4
That good news wasn’t enough to keep shares from continuing to fall, though. The genetic-sequencing company announced its fourth-quarter results after the market closed on Thursday.
5 Ways Vertex Pharmaceuticals Plans to Grow in 2017 and Beyond
However, Vertex CEO Jeff Leiden said on Monday at the J.P. Morgan Healthcare Conference that “business has never been stronger.” He also emphasized that the company has a clear pathway to growth in 2017 and beyond.
Secretive Biotech Unicorn Moderna Unveils Pipeline, Financials
Moderna Therapeutics Inc., one of the best-funded private biotechnology companies in the U.S., unveiled its long-secret research and development pipeline on Monday, including experimental vaccines, cancer treatments and a cardiovascular therapy. The Cambridge, Massachusetts-based startup has about $1.3 billion in cash on hand from investors, pharmaceutical partners and government grants, according to a presentation Monday at the J.P.Morgan Chase & Co.
Will Spinraza Supercharge Biogen’s Top Line Next Year?
SMA is an inherited neurological disorder that results in progressive muscle wasting, impacting a person’s ability to move and even breathe. Although this disease is rare, with a U.S. incidence rate of 1 in 10,000 live births, it is the leading genetic cause of death in infants, and prior to Spinraza’s approval it lacked any form of effective pharmaceutical intervention.
What Happened in the Stock Market Today
Fitbit shares spiked 7% following a rare piece of encouraging news about the fitness device maker’s holiday sales trends. Its activity tracking software was the second most-popular download among free apps on Apple ‘s iTunes this past week, beating such heavyweights as Snapchat, YouTube, and Instagram.
Seattle Genetics Plunges After Drug Studies Halted on Deaths
Seattle Genetics Inc. plunged the most in five years after U.S. regulators halted several early-stage blood cancer studies following the deaths of four patients who suffered from liver damage. The Food and Drug Administration halted the trials testing Seattle Genetics’s acute myeloid leukemia, or AML, therapy, called SGN-CD33A.
3 Precision Medicine Stocks to Buy in January
The National Institutes of Health defines precision medicine as “an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person.” For several companies, this approach is already a reality — and it has created opportunities for investors.
How to Get a Better Night’s Sleep
Most people know they need to eat right and exercise to be healthy. But what about sleep? We spend about one-third of our lives asleep, and sleep is essential to better health.
This Startup Will Sequence Your DNA, So You Can Contribute To Medical Research
The price to sequence the human genome has dropped from $100 million in 2001 to just a few thousand dollars today. It’s now cheap enough that some people are starting to get sequenced out of sheer curiosity about what they might uncover.
The Most Expensive Drugs of 2016
Prescription drug prices have gotten out of control for many Americans and many insurers. Some drugs cost as much as premium sports cars.
Better Buy: bluebird bio, Inc. vs. Kite Pharma
Several clinical-stage biotechs are developing therapies usingchimeric antigen receptor T cells . Two of them in particular have enjoyed some good news in 2016: bluebird bio .